S100B and psychotic disorder: Specifically, reduced ALPS index values in patients relative to non-psychiatric controls align with a growing body of literature implicating astrocytic dysfunction, AQP4 misregulation, and elevated peripheral S100B levels in the acute phase of psychosis.